PI-88 and Related Heparan Sulfate Mimetics
Authors:
- 10 April 2020
- book chapter
- Published by Springer Nature
- Vol. 1221, 473-491
Abstract
The heparan sulfate mimetic PI-88 (muparfostat) is a complex mixture of sulfated oligosaccharides that was identified in the late 1990s as a potent inhibitor of heparanase. In preclinical animal models it was shown to block angiogenesis, metastasis and tumor growth, and subsequently became the first heparanase inhibitor to enter clinical trials for cancer. It progressed to Phase III trials but ultimately was not approved for use. Herein we summarize the preparation, physicochemical and biological properties of PI-88, and discuss preclinical/clinical and structure-activity relationship studies. In addition, we discuss the PI-88-inspired development of related HS mimetic heparanase inhibitors with improved properties, ultimately leading to the discovery of PG545 (pixatimod) which is currently in clinical trials.Keywords
This publication has 97 references indexed in Scilit:
- The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold StandardMolecules, 2018
- Recent advances in the discovery of heparanase inhibitors as anti-cancer agentsEuropean Journal of Medicinal Chemistry, 2016
- Heparanase: A Rainbow Pharmacological Target Associated to Multiple Pathologies Including Rare DiseasesFuture Medicinal Chemistry, 2016
- Heparanase: a target for drug discovery in cancer and inflammationBritish Journal of Pharmacology, 2007
- Development of Heparanase Inhibitors for Anti-Cancer TherapyCurrent Medicinal Chemistry, 2006
- The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and InflammationMini-Reviews in Medicinal Chemistry, 2004
- Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasisNature Medicine, 1999
- Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasisNature Medicine, 1999
- Human platelet heparanase: purification, characterization and catalytic activityBiochemical Journal, 1998
- Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour‐cell‐derived heparanasesInternational Journal of Cancer, 1987